Drug
Trotabresib clinical trials
Also written CC-90010.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Celgene (3) · Dana-Farber Cancer Institute (1) · Bristol-Myers Squibb (1)
Often tested with
Tested in the same studies.
Ezobresib (1) · Temozolomide (1)
Studies
Open first, then newest update. How each study uses trotabresib is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's LymphomasTerminatedPhase 1CelgeneNCT03220347Written as CC-90010
- Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric CancerCompletedPhase 1Dana-Farber Cancer InstituteNCT03936465Written as BMS-986378
- A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed GlioblastomaTerminatedPhase 1CelgeneNCT04324840Written as CC-90010
- CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and GlioblastomaTerminatedPhase 1CelgeneNCT04047303Written as CC-90010
- A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid TumorsWithdrawnPhase 1Bristol-Myers SquibbNCT05678283Written as [14C]CC-90010
Given in every arm · 1 — trotabresib is usual care beside what is tested
Codes
What other systems call trotabresib · ClinicalTrials.gg INT017010
- UNII (FDA) K424WH3WU0TROTABRESIBOne source FDA
- NCI Thesaurus C151951TrotabresibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | K424WH3WU0 | TROTABRESIB | One source FDA |
| NCI Thesaurus | C151951 | Trotabresib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.